Respiratory Virus Season 2026: What Primary Care Doctors Want Families to Know About COVID-19, Flu, and RSV

Bottom line: As of late March 2026, COVID-19, influenza, and RSV are all still circulating in the United States, though activity levels vary by region and week. For most healthy people, these infections can be managed at home. But for older adults, infants, pregnant people, and those with chronic medical conditions, early testing and timely treatment can make a meaningful difference.

Here’s what primary care doctors want families to understand right now.

1. Where We Are Now: A CDC Snapshot

According to the CDC Respiratory Virus Data Dashboard, influenza, COVID-19, and RSV continue to show measurable activity nationwide in late winter 2026. In many parts of the country, flu activity peaked earlier in the season and is trending downward, while COVID-19 levels have fluctuated with regional surges. RSV, which often peaks earlier in winter, is declining in several regions but has not disappeared.

National trends can shift quickly. The CDC updates its surveillance weekly, tracking emergency department visits, lab positivity rates, hospitalizations, and deaths. Activity is not uniform: what is declining in one region may still be rising in another.

For families, the key takeaway is simple: respiratory viruses are still circulating. If someone in your household develops symptoms, it is reasonable to consider testing and to stay home while sick.

2. Why Symptoms Overlap — and When Testing Helps

COVID-19, influenza, and RSV share many of the same symptoms:

Fever or chills
Cough
Sore throat
Runny or stuffy nose
Fatigue
Body aches
Headache

COVID-19 may also cause loss of taste or smell (less common than early in the pandemic), and gastrointestinal symptoms can occur with any of these viruses. RSV in infants may show up as wheezing, poor feeding, or pauses in breathing.

Because symptoms overlap, clinicians often use testing to guide treatment decisions—especially for people at higher risk. Rapid antigen tests for COVID-19 are widely available. Many clinics and urgent care centers offer combination PCR or rapid molecular panels that test for COVID-19, influenza, and RSV at the same time.

Testing matters most when the result would change what happens next—for example, whether to prescribe antiviral medication.

3. Who Is Most at Risk This Season

CDC guidance highlights several groups at higher risk for severe disease from COVID-19, influenza, or RSV:

Adults age 65 and older
Infants, especially under 6 months
Pregnant and recently pregnant people
People with chronic heart, lung, kidney, or liver disease
People with diabetes or obesity
Immunocompromised individuals (due to illness or medications)
Residents of long-term care facilities

For these groups, early contact with a primary care clinician is important if symptoms develop. Antiviral treatments for influenza and COVID-19 work best when started early—usually within the first few days of illness.

4. How Primary Care Doctors Decide on Testing and Treatment

Primary care clinicians follow CDC and professional guidance, including recommendations summarized by the American Academy of Family Physicians.

Influenza

For patients at high risk or with severe symptoms, clinicians may prescribe antiviral medications such as oseltamivir (Tamiflu) or baloxavir. According to CDC flu guidance for the 2025–2026 season, treatment is most effective when started within 48 hours of symptom onset, but it may still benefit high-risk patients even if started later.

COVID-19

For eligible high-risk outpatients, CDC clinical care guidance recommends antivirals such as nirmatrelvir-ritonavir (Paxlovid) or a short course of intravenous remdesivir. These medications reduce the risk of hospitalization and severe outcomes when started within about five days of symptom onset.

Not everyone with COVID-19 needs antiviral medication. For younger, otherwise healthy individuals with mild illness, supportive care at home—rest, fluids, fever control—remains appropriate.

RSV

There is no routine outpatient antiviral treatment for RSV. Care is supportive. In infants and older adults at risk of complications, clinicians monitor closely for breathing difficulty or dehydration.

Across all three viruses, doctors weigh factors like age, medical history, medication interactions, pregnancy status, and how many days have passed since symptoms began.

5. Vaccines and RSV Prevention in 2025–2026

Vaccination remains one of the most effective ways to reduce severe disease.

Influenza Vaccine

The CDC recommends annual flu vaccination for everyone 6 months and older. Vaccines are updated each season to match circulating strains as closely as possible.

COVID-19 Vaccine

Updated COVID-19 vaccines targeting currently circulating variants are recommended for most adults and children, with additional doses for certain high-risk individuals. The CDC notes that flu and COVID-19 vaccines can be given at the same visit.

RSV Prevention

RSV prevention has expanded in recent seasons:

Maternal RSV vaccination during pregnancy (typically 32–36 weeks) can help protect newborns in their first months of life.
Nirsevimab, a long-acting monoclonal antibody, is recommended for many infants entering their first RSV season if maternal vaccination was not given in the recommended window.
RSV vaccines for older adults are recommended for adults 75 and older, and for some adults 60–74 with risk factors, after discussion with a clinician.

These options are not interchangeable in all cases, and decisions depend on timing, age, and risk factors. Families should speak with their primary care clinician or pediatrician to clarify eligibility.

6. When to Stay Home — and When to Seek Urgent Care

Stay home if you have fever, significant cough, vomiting, or feel unwell enough that you would not normally go to work or school. Many public health authorities recommend remaining home until fever has resolved for at least 24 hours without fever-reducing medication and symptoms are improving.

Seek urgent or emergency care for:

Difficulty breathing or shortness of breath
Chest pain or pressure
Confusion or new disorientation
Bluish lips or face
Severe dehydration
In infants: poor feeding, pauses in breathing, or unusual lethargy

When in doubt, call your primary care office. Many clinics can triage by phone or telehealth and determine whether you need testing, antiviral treatment, or emergency evaluation.

7. Insurance, Access, and Practical Next Steps

In the United States, vaccines recommended by the CDC’s Advisory Committee on Immunization Practices are typically covered without cost-sharing by most private insurance plans when given in-network. Medicare covers influenza, COVID-19, and pneumococcal vaccines under Part B, and other recommended adult vaccines under Part D. Medicaid coverage varies by state but generally includes ACIP-recommended vaccines.

Outpatient antivirals such as oseltamivir and nirmatrelvir-ritonavir are usually covered by insurance, though copays may apply depending on the plan. Coverage for testing can vary based on setting and insurance type.

Pharmacies, primary care offices, community clinics, and local health departments remain key access points for vaccination and testing.

8. What Public Health Officials Are Still Watching

CDC surveillance continues to monitor:

Shifts in dominant influenza strains
Changes in circulating COVID-19 variants
Regional RSV activity
Hospitalization trends among older adults and children

Respiratory virus patterns can change over weeks, not months. Following CDC updates and staying in contact with your primary care clinician remain the most reliable ways to navigate the season.

What this means for families: Know your household’s risk factors. Keep flu and COVID-19 vaccines up to date. Ask about RSV prevention if you are pregnant, have an infant, or are an older adult. If someone gets sick, test early if they are high risk, and contact your clinician promptly about possible antivirals. Most infections are manageable—but timing and awareness matter.

Sources

This article is for general informational purposes only and is not medical advice. Research findings can be early, limited, or subject to change as new evidence emerges. For personal guidance, diagnosis, or treatment, consult a licensed clinician. For current outbreak or public health guidance, follow your local health department, the CDC, or another relevant public health authority.